Quantum-Si to Provide a Business Update and Report Third Quarter 2026 Financial Results on November 5, 2026GlobeNewsWire · Oct 16, 2026
Quantum-Si Regains Compliance with Nasdaq Minimum Bid Price RequirementGlobeNewsWire · Oct 15, 2026
Leading Indicators For The October Breakout CycleSeeking Alpha · Oct 11, 2026
Beyond Elon Musk's Neuralink: Two Public Stocks With a Stake in the Brain RaceInvestorPlace · Oct 9, 2026
2 Brain-Computer Interface Stocks to Watch While Neuralink Stays PrivateInvestor Place · Oct 9, 2026
Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus™ Development ProgramGlobeNewsWire · Oct 8, 2026Quantum-Si incorporated operates within the life sciences sector, focusing on the creation of an advanced platform for individual molecule detection. This innovative technology is designed to streamline sample preparation and subsequent sequencing processes. The company offers a unique, proprietary single molecule detection system that draws on advancements from the semiconductor industry.
| Date | Est. | Actual | |
|---|---|---|---|
| Aug 13, 2026 | -$0.11 | -$0.11 | Beat |
| May 7, 2026 | -$0.12 | -$0.10 | Beat |
| Mar 3, 2026 | -$0.14 | -$0.08 | Beat |
| Nov 5, 2025 | -$0.12 | -$0.17 | Miss |
| Aug 5, 2025 | -$0.16 | -$0.16 | Beat |
| May 15, 2025 | -$0.17 | -$0.11 | Beat |